Focal Muscular Vibration to Treat Upper Limb Spasticity in Stroke
Stroke
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Upper limb, Rehabilitation, Focal Muscular Vibration
Eligibility Criteria
Inclusion Criteria:
- first cerebral stroke
- 2 weeks up to 12 months post the acute event (subacute patients)
- age between 35-80 years
- single cortical or subcortical event
- spastic paresis of the upper limb (Modified Ashworth Scale score ≥ 2)
- ability to give written consent
- compliance with the study procedures
Exclusion Criteria:
- comorbidities affecting the paretic upper limb (fractures, trauma or peripheral neuropathies)
- cognitive and/or communicative disability (e.g. due to brain injury): inability to understand the instructions required for the study
- treatment with focal or systemic antispastic drugs (i.e. baclofen, thiocolchicoside, tizanidine).
Sites / Locations
- Irene Aprile
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Group Flexors (A)
Group Extensors (B)
Group A was treated by applying FMV to the flexor muscles of the upper limb (brachial biceps and carpal flexors). Patients will be treated with FMV for three consecutive days: each session consisted of three sessions of 10 minutes each, interspersed with one minute of rest. A vibration frequency of 100 Hz has been applied, according to the literature.
Group b was treated by applying FMV to the extensors muscles of the upper limb (triceps brachial and carpus extensors). Patients will be treated with FMV for three consecutive days: each session consisted of three sessions of 10 minutes each, interspersed with one minute of rest. A vibration frequency of 100 Hz has been applied, according to the literature.